GLP-1 INTELLIGENCE
LIVEStay ahead of the GLP-1 market.
Clinical research, industry moves, and regulatory shifts — curated from the sources that matter. Updated hourly.
16 articles
STAT+: GLP-1 drugs are almost single-handedly forcing employers to reconsider workers’ health care
Another hospital system sues CVS Health, how Medicaid cuts will change everything, and more
FTC, States Sue Amazon Over Secret Ad Surcharge Scheme
FTC and 22 state attorneys general allege Amazon concealed unfair charges in its digital advertising auction pricing Today, 22 states joined the Federal Trade Commission in filing suit against Amazon, alleging that the company engaged in deceptive and unfair practices that secret
Telehealth Access to Mifepristone — Evaluating Reproductive-Coercion Arguments
New England Journal of Medicine, Ahead of Print.
FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults.
FDA Issues Emergency Use Authorization for Generic Drug to Prevent New World Screwworm in Cattle
FDA issues Emergency Use Authorization (EUA) for Bimectin (ivermectin) injection for the prevention of New World screwworm (NWS) infestations (myiasis) in cattle when administered within 24 hours of birth, at the time of castration, or at the appearance of a wound.
FTC Finalizes Orders with Cox Media Group, Two Other Firms Settling Charges They Deceived Customers About “Active Listening” AI-Powered Marketing Service
The Federal Trade Commission finalized orders requiring Cox Media Group (CMG) and two other firms to pay a total of $930,000 to settle allegations they deceived customers by falsely claiming to offer an AI-powered service that could target localized ads based on conversations cap
FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer
The U.S. Food and Drug Administration today approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule.
FTC Announces 2027 Telemarketer Fees to Access the National Do Not Call Registry
The Federal Trade Commission today announced new fees for telemarketers to access phone numbers on the National Do Not Call (DNC) Registry for Fiscal Year 2027 which begins on October 1, 2026. View Press Release
FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar
The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.
FTC Approves Final Consent Order in Ascension Health-AmSurg Deal
The Federal Trade Commission finalized a consent order involving Ascension Health Alliance’s (Ascension) proposed $3.9 billion acquisition of AmSurg LLC. View Press Release
Roche Gains Rights to Hanmi Obesity Drug That Reduces Fat, Preserves Muscle
Hanmi Pharmaceutical’s drug is designed to activate a receptor in skeletal muscle to both increase muscle mass and reduce fat. This engineered peptide gives Roche a clinical-stage asset that addresses a different target than the other obesity drugs in its pipeline. The post Roche
FTC Secures Order Resolving Antitrust Concerns with Zillow-Redfin Agreement
Proposed order ends allegedly unlawful agreement, requires Redfin to reenter market for internet listing services and positions company as a stronger competitor The Federal Trade Commission, joined by five states, today notified the court that it will file a stipulated order that
FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
The Federal Trade Commission filed an amicus brief in an antitrust case alleging that drug manufacturer Amgen illegally acquired exclusive rights to patent applications that it shaped to cover Enbrel—a drug used to treat rheumatoid arthritis and other inflammatory conditions—allo
FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia
The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) as the first-ever treatment for adults and children 8 years of age and older with glycogen storage disease type Ia (GSDIa)
Survodutide Once Weekly for the Treatment of Adults with Obesity
New England Journal of Medicine, Volume 395, Issue 8, Page 776-787, August 20/27, 2026.
Ready to build your GLP-1 program?
NexaCare handles the operational layer so your clinic can focus on patient outcomes.
Book a Demo →